688373.SHG Shanghai MicuRx Pharmaceutical Co. Ltd. A

Healthcare Pharmaceuticals Shanghai Stock Exchange
4.88 CNY
Close of Nov 4, 2026
4.09 7.61
Market cap
CNY 3.20B
P/E
-
P/B
19.21x
ROE
-46.1%
Dividend yield
0.28%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688373.SHG undervalued?

Graham number

The Graham number of Shanghai MicuRx Pharmaceutical Co. Ltd. A cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai MicuRx Pharmaceutical Co. Ltd. A fundamental analysis

No fundamental analysis for Shanghai MicuRx Pharmaceutical Co. Ltd. A yet.

Shanghai MicuRx Pharmaceutical Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai MicuRx Pharmaceutical Co. Ltd. A

Shanghai MicuRx Pharmaceutical Co., Ltd., a biopharmaceutical company, discovers, develops, and commercialize drugs for unmet medical needs. It is developing Contezolid (MRX-I) and Contezoilid acefosamil (MRX-4) oxazolidinone antibiotics for multidrug-resistant gram-positive bacteria; MRX-8 MRX, a polymyxin antibiotic, to target multidrug-resistant Gram-negative bacteria; MRX-5 for multidrug-resistant gram-negative bacteria; MRX-7 for multidrug-resistant gram-positive bacter…

Full company profile